Colon cancer screening with CT may also identify heart attack risk

December 01, 2004

CHICAGO - Virtual colonoscopy, an imaging procedure used for early identification of colon cancer, may also detect heart attack risk in patients, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).

"This early study points to the possibility of multiple diagnostic benefits for patients participating in certain colon cancer screenings," said lead author, Jesse A. Davila, M.D., a fellow in musculoskeletal radiology at the Mayo Clinic Jacksonville in Florida.

Computed tomographic (CT) colonography, more commonly known as virtual colonoscopy, is a minimally invasive procedure that tests for colon cancer by creating 2-D and 3-D fly-through images that identify such abnormalities as pre-cancerous polyps. Virtual colonoscopy requires no sedation and is less costly than conventional colonoscopy.

"With virtual colonoscopy providing a less invasive approach to diagnosing colon cancer, we wanted to measure whether additional information could be gained during the scan," Dr. Davila said. "Because cardiovascular disease is often asymptomatic prior to a major event, we hoped that we could use the scan to measure calcium deposit levels within the aorta and its branching vessels without the need for additional testing."

According to the Centers for Disease Control and Prevention, heart disease is the leading cause of death in the United States, followed closely by cancer. Colon cancer is the second leading cause of cancer deaths. The American Cancer Society recommends that men and women be screened for colon cancer beginning at age 50.

The researchers reviewed the records of 480 patients who received virtual colonoscopy exams at the Mayo Clinic in Rochester, Minn., from 1995 to 1998.

Medical records showed a direct correlation between high aortic calcium scores measured during the procedure and the nine patients who experienced heart attacks subsequent to the screening.

By noting calcification scores during virtual colonoscopy procedures, physicians may have an additional means of identifying patients at risk of developing cardiovascular disease, according to Dr. Davila.

"While larger, follow-up studies are necessary to help verify our results, we hope that identifying the possible synergies in medical testing will encourage individuals to take advantage of the diagnostic tools available to them," Dr. Davila said. "As a leading cause of death, colon cancer should be identified as early as possible. The potential benefits from additional diagnostic uses for virtual colonoscopy should encourage individuals to undergo this very important procedure."

Co-authors of this study are C. Daniel Johnson, M.D., Thomas R. Behrenbeck, M.D., and Tanya Hoskin.
-end-
Note: Copies of RSNA 2004 news releases and electronic images will be available online at RSNA.org/press04 beginning Monday, Nov. 29.

RSNA is an association of more than 37,000 radiologists, radiation oncologists and related scientists committed to promoting excellence in radiology through education and by fostering research, with the ultimate goal of improving patient care. The Society is based in Oak Brook, Ill.

Editor's note: The data in these releases may differ from those in the printed abstract and those actually presented at the meeting, as researchers continue to update their data right up until the meeting. To ensure you are using the most up-to-date information, please call the RSNA Newsroom between Nov. 27 and Dec. 3 at 312-949-3233.

Radiological Society of North America

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.